Guardian Pharmacy Services Reports Strong Revenue Growth

Guardian Pharmacy Services, Inc. Class A ( (GRDN) ) has released its Q4 earnings. Here is a breakdown of the information Guardian Pharmacy Services, Inc. Class A presented to its investors.

Guardian Pharmacy Services, Inc. is a prominent provider of long-term care pharmacy services, offering technology-enabled solutions to assist residents in long-term healthcare facilities across the United States.

Guardian Pharmacy Services, Inc. has reported its financial results for the fourth quarter and full year of 2024, showcasing significant revenue growth driven by organic expansion and strategic acquisitions. Despite a decrease in net income, the company achieved a notable increase in Adjusted EBITDA, reflecting operational efficiencies and successful vaccine clinic initiatives.

For the fourth quarter, Guardian reported a revenue increase of 20% year-over-year, reaching $338.6 million, primarily due to organic growth and acquisitions. The resident count rose by 14% to 186,000, while Adjusted EBITDA saw a 30% increase to $25.9 million. However, net income decreased to $11.8 million, impacted by tax provisions and share-based compensation expenses. For the full year, revenue climbed to $1.228 billion, with Adjusted EBITDA up by 19% to $90.8 million, although the company faced a net loss of $71.0 million due to significant share-based compensation expenses linked to its IPO.

Looking ahead, Guardian Pharmacy Services enters 2025 with a positive outlook, aiming for revenue between $1.330 billion and $1.350 billion, and Adjusted EBITDA ranging from $97.0 million to $101.0 million. The company remains focused on leveraging its growth momentum and meeting the needs of its long-term care residents.